Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.
about
Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuseInteractions of Opioids and HIV Infection in the Pathogenesis of Chronic PainThe macrophage: a therapeutic target in HIV-1 infectionCortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaineRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersHIV-1 associated dementia: symptoms and causesMechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disordersApoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease GHIV and antiretroviral therapy in the brain: neuronal injury and repairHIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorderHuman immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDSHippocampal Neuronal Loss in Infant Macaques Orally Infected with Virulent Simian Immunodeficiency Virus (SIV).Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia.Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.Time-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive DisordersMechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.Differential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat proteinMechanisms of HIV Transcriptional Regulation by Drugs of Abuse.Neuropsychiatric manifestations of HIV infection and AIDSNeurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transportAstrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression.Glutamate metabolism and HIV-associated neurocognitive disorders.Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disordersCharacterization of peripheral blood human immunodeficiency virus isolates from Hispanic women with cognitive impairment.Heme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders.Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposureImmunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification.Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.HIV-associated neurocognitive disorders: perspective on management strategiesHuman immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.HIV neurotoxicity: potential therapeutic interventionsIncreased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.HIV-1 neuropathogenesis: glial mechanisms revealed through substance abusePreferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.Protective effects of curcumin against human immunodeficiency virus 1 gp120 V3 loop-induced neuronal injury in rats.
P2860
Q26746336-5E2C52D8-AB11-40F3-8078-B073F97CFEECQ26768068-F20D7256-8958-4A18-89CE-A3015C7F3684Q26823236-B62DD36E-912D-4033-8668-10F0B40CADB6Q27013928-BD75CB04-545A-4DDF-9018-5F59F1F1F0A6Q27025573-55EFC201-D0A8-4337-8B86-C2EC05CA6CB5Q27473387-04A6B60B-867D-48C6-B6D3-FFA543B20E29Q28082139-F2E876A6-45FE-4015-9158-1239B14277E6Q28267535-D5B86347-57F6-4903-9163-257C87B7AC4AQ28279808-E3B8051C-165A-46E9-8B45-F8AB5FD79D95Q28394040-52AABF15-FE64-49A9-8ADE-679ADE28CB67Q30497248-F9A652CC-56DC-487D-8A81-6BDFE83A7A02Q33580220-DA9BFAF2-5ABA-4774-8669-1FD6C972EBB1Q33607923-CFBE3434-917E-4948-B579-A54EFA9B1AFBQ33647684-A5C27CB6-E6EA-4EF2-A128-7BCB1831235AQ33676881-5429746B-63F9-4095-8565-6B41959B56DBQ33734695-EDCB618B-7416-4072-944C-EA4C9678F725Q33770575-AC958396-0EE2-4174-89D2-17E210DB9A44Q33786188-088027F1-DD7B-45B9-B025-E9F09C2BC2A9Q33815611-3E93C295-84DF-4F10-B273-B293DD713BE9Q33868874-B5406990-83F1-46A9-9888-EC473A7B0B3EQ33870898-3C4A4851-1F2D-4DDD-8FF2-F46927973AF9Q33888584-E2DE374F-5819-4916-9B17-047D55220970Q33903612-111AE891-1027-4163-965F-EDF0E68183BDQ34016222-184CD654-DE31-448F-83AF-BBF9EE5466FFQ34077857-C8B6547F-38DF-4F75-B2FE-E1B8C39D8428Q34139883-91268EED-F473-429B-B84B-59C4FE4C12C0Q34193846-131CCF39-0F93-4F2E-A5D6-A35F871C4614Q34281974-1E6D4B0E-2C89-4F52-8706-FEFE8AF777EFQ34415545-AB97FC8A-6124-4C74-BF3C-47F46D3F6728Q34540333-79D6978C-C3C9-41C7-A7E8-E14EAC989755Q34652590-2CFB63E2-E2C5-4EB0-B64F-01E0A7AA1548Q34664366-D503AACD-6505-44A1-AD2A-AD4E3FB7F07DQ34795283-15F1C0FA-2BFA-4AAE-A639-2A52F724BA44Q34805533-6485EA3E-A5AA-4272-9765-9AF32715808FQ34914245-3D5853BD-5475-4134-A2A2-57B2E11C42B1Q35009465-94ACB54D-24AF-47D0-AFBA-A91D0C7A8CE6Q35009483-AB0FA508-6480-4687-AFAE-391C5F688F69Q35019404-1AFF2A3B-9297-41A8-B273-355E70AD92E5Q35033471-13B9666C-55F9-435C-ADEB-1D735D4B771FQ35157729-1DCF451F-2573-4C6E-B73B-9D509A419CEC
P2860
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.
@ast
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.
@en
type
label
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.
@ast
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.
@en
prefLabel
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.
@ast
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.
@en
P356
P1476
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.
@en
P2093
P304
P356
10.1086/344528
P407
P478
186 Suppl 2
P577
2002-12-01T00:00:00Z